Read, Watch or Listen

A mid-stage study published in the Journal of the American Medical Association found that LSD significantly reduced anxiety symptoms in patients with moderate-to-severe generalized anxiety disorder. Researchers tested various doses, with the 100-microgram dose showing the most significant long-term benefits, lasting up to three months for some patients. While the study had some limitations, including the inability to fully blind participants, the results pave the way for further research and potential FDA approval of LSD as a treatment for anxiety. This follows renewed interest in psychedelic therapies for mental health conditions.

Prepared by Olivia Bennett and reviewed by editorial team.